| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157542 | American Journal of Kidney Diseases | 2013 | 8 Pages |
Abstract
In the United States, the lifetime risk of developing CKD stage 3a+ is high, emphasizing the importance of primary prevention and effective therapy to reduce CKD-related morbidity and mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Morgan E. MD, MHS, Eric K.H. MS, Dorry L. MD, PhD, Josef MD, PhD,